Remove Cerebrovascular Disease Remove Certification Remove Physiology
article thumbnail

CorVascular’s VasoGuard Earns FDA 510(k) Clearance

DAIC

Early identification allows for timely initiation of guideline-directed medical therapy for secondary prevention of cardiovascular disease, cerebrovascular disease, and limb events. The VasoGuard V-Series signifies a significant step forward for physiologic testing in international standards compliance.